Cantais Aymeric, Hammouda Zeineb, Mory Olivier, Patural Hugues, Stephan Jean-Louis, Gulyaeva Lyudmyla, Darmon Michael
Pediatrics Emergency department, Saint-Etienne University Hospital, Saint-Etienne, France.
Intensive Care Unit, Fattouma Bourguiba Monatir University hospital, Monatir, Tunisia.
Pediatr Nephrol. 2016 Aug;31(8):1355-62. doi: 10.1007/s00467-016-3313-9. Epub 2016 Mar 21.
Contrast-induced acute kidney injury (CI-AKI) is a common pathology among adult patients, with an incidence ranging from 3-25 % depending on risk factors. Little information is available regarding CI-AKI incidence, risk factors, and prognostic impact in the pediatric population.
We performed a retrospective study of pediatric patients who underwent computed tomography (CT) scan with iodinated contrast media injection between 2005 and 2014 in five pediatric units of a university hospital. CI-AKI was defined according to Kidney Disease/Improving Global Outcomes (KDIGO) criteria.
Of 346 identified patients, 233 had renal function follow-up and were included in our analyses. CI-AKI incidence was 10.3 % [95 % confidence interval (CI) 6.4-14.2 %]. CI-AKI was associated with 30-day unfavorable outcome before (45.8 % vs. 19.7 %, P = 0.007) and after [odds ratio (OR) 3.6; 95 % CI 1.4-9.5] adjustment for confounders. No independent risk factors of CI-AKI were identified.
CI-AKI incidence was as high as 10.3 % following intravenous contrast media administration in the pediatric setting. As reported among adults, CI-AKI was associated with unfavorable outcome after adjustment for confounders. Although additional studies are needed in the pediatric setting, our data suggest that physicians should maintain a high degree of suspicion toward this complication among pediatric patients.
对比剂诱导的急性肾损伤(CI-AKI)是成年患者中常见的病理情况,其发病率因危险因素不同而在3%至25%之间。关于CI-AKI在儿科人群中的发病率、危险因素及预后影响的信息较少。
我们对2005年至2014年期间在一家大学医院的五个儿科科室接受碘对比剂注射的计算机断层扫描(CT)的儿科患者进行了一项回顾性研究。CI-AKI根据肾脏病改善全球预后(KDIGO)标准进行定义。
在346例确诊患者中,233例进行了肾功能随访并纳入我们的分析。CI-AKI发病率为10.3%[95%置信区间(CI)6.4 - 14.2%]。在对混杂因素进行调整之前(45.8%对19.7%,P = 0.007)和之后[比值比(OR)3.6;95%CI 1.4 - 9.5],CI-AKI与30天不良结局相关。未发现CI-AKI的独立危险因素。
在儿科环境中静脉注射对比剂后,CI-AKI发病率高达10.3%。正如在成人中所报道的那样,在对混杂因素进行调整后,CI-AKI与不良结局相关。尽管在儿科环境中还需要进一步研究,但我们的数据表明医生应对儿科患者中的这种并发症保持高度怀疑。